BARRAVECCHIA, Ivana
 Distribuzione geografica
Continente #
EU - Europa 761
NA - Nord America 714
AS - Asia 97
AF - Africa 2
OC - Oceania 2
Totale 1.576
Nazione #
US - Stati Uniti d'America 674
IT - Italia 461
GB - Regno Unito 92
DE - Germania 62
UA - Ucraina 41
CA - Canada 38
FR - Francia 24
VN - Vietnam 23
CN - Cina 22
SG - Singapore 16
IE - Irlanda 14
IN - India 14
DK - Danimarca 13
FI - Finlandia 13
PL - Polonia 10
SE - Svezia 9
ES - Italia 5
IR - Iran 5
NL - Olanda 4
PH - Filippine 4
GR - Grecia 3
HK - Hong Kong 3
PK - Pakistan 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
MX - Messico 2
TW - Taiwan 2
AT - Austria 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
RU - Federazione Russa 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 1.576
Città #
Chandler 111
Pisa 70
Fairfield 51
Milan 47
Woodbridge 44
Boardman 43
Southend 39
Rome 38
San Mateo 38
Houston 37
Ottawa 37
Ann Arbor 29
Seattle 29
Wilmington 28
Cambridge 22
Jacksonville 22
Ashburn 21
Genoa 17
Naples 17
Dong Ket 13
Stevenage 13
Dublin 12
Falls Church 12
Lawrence 12
Helsinki 11
Moncalieri 11
Beijing 10
Florence 10
Fremont 10
Portsmouth 10
Sciacca 10
Gargallo 9
Turin 9
Genova 8
Palermo 8
Sivakasi 8
Cascina 6
San Diego 6
Warsaw 6
Albavilla 5
Dearborn 5
Pontedera 5
Scuola 5
Serra 5
Singapore 5
Augusta 4
Bologna 4
Brooklyn 4
Buti 4
Las Pinas 4
Lucca 4
Madrid 4
Mariano Comense 4
Marseille 4
Redmond 4
San Ginesio 4
West Jordan 4
Agios Nikolaos 3
Amsterdam 3
Campiglia Marittima 3
Canzo 3
Carrara 3
Catania 3
Cles 3
Corigliano Calabro 3
Erlangen 3
Forlì 3
Munich 3
Ovada 3
Padova 3
Redwood City 3
Sassari 3
Shanghai 3
Trieste 3
Vicopisano 3
Acton 2
Bordeaux 2
Castel Campagnano 2
Central 2
Chennai 2
Chiswick 2
Domodossola 2
East Ham 2
Hangzhou 2
Livorno 2
London 2
Mexico City 2
Multan 2
Newcastle upon Tyne 2
Newport 2
Noida 2
Norwalk 2
Novara 2
Old Bridge 2
Pasadena 2
Pietra Ligure 2
Pietrasanta 2
Poznan 2
Pralungo 2
Reggio Calabria 2
Totale 1.116
Nome #
MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion 201
Human pathophysiological adaptations to the space environment 157
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells 156
Pitting Corrosion Within Bioreactors for Space Cell-Culture Contaminated by Paenibacillus glucanolyticus, a Case Report 135
Microgravity and space radiation inhibit autophagy in human capillary endothelial cells, through either opposite or synergistic effects on specific molecular pathways 132
Enriching the arsenal of pharmacological tools against MICAL2 113
Optimal low-intensity pulsed ultrasound stimulation for promoting anti-inflammatory effects in macrophages 102
A comprehensive molecular and morphological study of the effects of space flight on human capillary endothelial cells: sample quality assessment and preliminary results. 100
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response 98
Hypergravity activates a pro-angiogenic homeostatic response by human capillary endothelial cells 91
Inducible pluripotent stem cells to model and treat inherited degenerative diseases of the outer retina: 3d-organoids limitations and bioengineering solutions 74
MF595871.1, Paenibacillus glucanolyticus strain MSL3066 16S ribosomal RNA gene, partial sequence, GenBank Deposit 67
MF595853.1, Paenibacillus glucanolyticus strain MSL3066 16S ribosomal RNA gene, partial sequence. GenBank Deposit 65
MICAL2 is essential for myogenic lineage commitment 63
Top–Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer 46
Totale 1.600
Categoria #
all - tutte 7.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202087 13 0 5 4 10 8 13 6 13 4 1 10
2020/2021289 17 18 7 17 8 41 71 19 19 11 23 38
2021/2022233 16 30 8 8 0 4 18 56 19 31 16 27
2022/2023362 24 41 26 46 27 31 17 20 54 26 34 16
2023/2024379 20 26 44 39 23 20 22 26 27 29 29 74
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 1.600